Patent ID: 8519001
Filing Date: 2013-08-27
Classification: A61P,C07B,C07C,C07D

Abstract:
1. A method of treating or suppressing a mitochondrial disorder or mitochondrial dysfunction, wherein the disorder or dysfunction is selected from the group consisting of Autistic Disorder, Friedreich's Ataxia, Huntington's Disease, Leber's Hereditary Optic Neuropathy (LHON), and Parkinson's disease, the method comprising administering to a subject a therapeutically effective amount of one or more compounds of Formula I: where R is selected from the group consisting of: where the * indicates the point of attachment of R to the remainder of the molecule; R R R —OR R R M and M′ are independently selected from hydrogen, —C(O)—R or a salt, a stereoisomer, or a mixture of stereoisomers thereof.